1995
DOI: 10.1099/0022-1317-76-7-1791
|View full text |Cite
|
Sign up to set email alerts
|

Point mutations in the coat protein of cucumber mosaic virus affect symptom expression and virion accumulation in tobacco

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
49
0
3

Year Published

1997
1997
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 92 publications
(54 citation statements)
references
References 10 publications
2
49
0
3
Order By: Relevance
“…Using pseudorecombinants, these authors concluded that CMV RNAs 1 and 2 were involved in determining symptom severity. On the other hand, Sugiyama et al (2000) and Suzuki et al (1995) reported that the severity of systemic mosaic symptoms in tobacco was controlled by amino acids 111, 124 and 129 of the CMV CP gene on RNA 3. The unusual severe stunting and leaf blistering of N. glutinosa, but not other Nicotiana species by R-CMV was mapped to amino acid position 193 of the CP gene (Carrère et al 1999;Szilassy et al 1999).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Using pseudorecombinants, these authors concluded that CMV RNAs 1 and 2 were involved in determining symptom severity. On the other hand, Sugiyama et al (2000) and Suzuki et al (1995) reported that the severity of systemic mosaic symptoms in tobacco was controlled by amino acids 111, 124 and 129 of the CMV CP gene on RNA 3. The unusual severe stunting and leaf blistering of N. glutinosa, but not other Nicotiana species by R-CMV was mapped to amino acid position 193 of the CP gene (Carrère et al 1999;Szilassy et al 1999).…”
Section: Discussionmentioning
confidence: 99%
“…Maize appears to be resistant to systemic infection by most subgroup II strains (Wahyuni et al 1992;Carrère et al 1999;Ryu et al 1998). CMV sequences that control symptom type and virulence have been mapped to the 3a and CP genes on RNA 3 (Carrère et al 1999;Suzuki et al 1995;Sugiyama et al 2000;Szilassy et al 1999), but RNAs 1 and 2 have also been implicated (Roossinck and Palukaitis 1990;Zhang et al 1994;Hellwald et al 2000b;Soards et al 2002).…”
Section: Introductionmentioning
confidence: 99%
“…As the cucumoviral 2b protein is involved in the control of symptom expression (Ding et al 1995;Soards et al 2002), replacing the 2b sequence of the CMV2-A1 vector with that of an attenuated CMV such as CM95 (Kosaka and Fukunishi 1997) would reduce the viral symptom. Also, it may be effective to use a pseudorecombinant virus consisting of CMV2-A1 and RNA 1 and/or RNA 3 of other strains of CMV, because it is known that symptom expression is also affected by RNA 1 or RNA 3 in addition to the activity of the 2b protein (Shintaku et al 1992;Suzuki et al 1995). We have found that a pseudorecombinant virus consisting of CMV2-A1 and RNA 1 and RNA 3 of the leguminous strain of CMV (CMV-L; Karasawa et al 1997) infects N. benthaminana plants without exhibiting visible symptoms ( Figure 5).…”
Section: Discussionmentioning
confidence: 99%
“…MP plays an important role in cell to cell movement of the virus. While coat protein is required for encapsidation of the genomic RNAs into virus particles, important in aphid transmission [7,30] and affecting symptom expression [42,49]. CMV strains are divided into two subgroups I and II [3,31,33] and subgroup I is subdivided into IA and IB based on nucleotide sequence of the 3 0 untranslated region of RNA3 [37].…”
Section: Introductionmentioning
confidence: 99%